Skip to content
2000
Volume 12, Issue 9
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Building cellular models of disease based on the approach of Cellular Systems Biology (CSB)™ has the potential to improve the process of creating drugs as part of the continuum from early drug discovery through drug development and clinical trials and diagnostics. This paper focuses on the application of CSB to early drug discovery. We discuss the integration of protein-protein interaction biosensors with other multiplexed, functional biomarkers as an example in using CSB to optimize the identification of quality lead series compounds.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/138620709789383286
2009-11-01
2025-07-11
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/138620709789383286
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test